Pamela Anne Maher
Works at
Salk Institute for Biological Studies
Research professor
Sources: reporter.nih.gov
Grants and prizes
U01, Long-term, non-clinical toxicology for advancing CMS121 to Phase 2 trials for AD, U01AG084549, 2024–2027, 12 Aug 2026
R44, Paving the Way to Phase 2 Trials of CMS121 for Alzheimer's Disease, R44AG085775, 2024–2025, 26 Sept 2024
R01, Using geroscience to understand and treat Alzheimer's disease, R01AG069206, 2020–2026, 13 Jun 2024
Sources: reporter.nih.gov